Open Journal of Rheumatology and Autoimmune Diseases
Vol.5 No.4(2015), Paper ID 60859, 9
pages
DOI:10.4236/ojra.2015.54017
Rational Usage of Disease Modifying Anti-Rheumatic Drugs with the Guidance of EULAR and ACR Suggestions
Zuhal Örnek, Metin Işık, Nesibe Karahan Yeşil, İsmail Doğan, Hatice Şahin, Ali Erdem Baki
Department of Pediatrics, Faculty of Medicine, Bülent Ecevit University, Zonguldak, Turkey
Division of Rheumatology, Department of Internal Medicine, Faculty of Medicine, Bülent Ecevit University, Zonguldak, Turkey
Department of Rheumatology, Ankara Education and Research Hospital, Ankara, Turkey
Division of Rheumatology, Department of Internal Medicine, Faculty of Medicine, Çorum Hitit University,
Çorum, Turkey
Department of Internal Medicine, Faculty of Medicine, Bülent Ecevit University, Zonguldak, Turkey
Department of Physical Medicine and Rheabilitation, Faculty of Medicine, Bülent Ecevit University, Zonguldak, Turkey
Copyright © 2015 Zuhal Örnek, Metin Işık, Nesibe Karahan Yeşil, İsmail Doğan, Hatice Şahin, Ali Erdem Baki et al. This is
an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any
medium, provided the original work is properly cited.
How to Cite this Article
Örnek, Z. , Işık, M. , Yeşil, N. , Doğan, İ. , Şahin, H. and Baki, A. (2015) Rational Usage of Disease Modifying Anti-Rheumatic Drugs with the Guidance of EULAR and ACR Suggestions.
Open Journal of Rheumatology and Autoimmune Diseases,
5, 104-112. doi:
10.4236/ojra.2015.54017.